Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Olivia Hayward"'
Autor:
Ben Parker, Tom Ward, Olivia Hayward, Ian Jacob, Erin Arthurs, Debbie Becker, Sarah-Jane Anderson, Vasiliki Chounta, Nicolas Van de Velde
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245955 (2021)
IntroductionCombination antiretroviral therapy (cART) improves outcomes for people living with HIV (PLWH) but requires adherence to daily dosing. Suboptimal adherence results in reduced treatment effectiveness, increased costs, and greater risk of re
Externí odkaz:
https://doaj.org/article/de2ab2059db94ba99b8da8d07fa7d875
Autor:
Alan Oglesby, Karin Butler, Yogesh Punekar, Olivia Hayward, Lee Alexandra Evitt, Sarah-Jane Anderson, I. Jacob
Publikováno v:
Journal of managed carespecialty pharmacy. 27(7)
BACKGROUND: Dolutegravir(DTG)/lamivudine(3TC) is the first 2-drug regimen recommended as an initial treatment for people living with HIV (PLHIV). OBJECTIVE: To assess the cost-effectiveness and potential budget impact of DTG/3TC in the US healthcare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6544cf38bd3508ea866379f7f0af3612
https://pubmed.ncbi.nlm.nih.gov/34185564
https://pubmed.ncbi.nlm.nih.gov/34185564
Autor:
Phil McEwan, Alan Oglesby, Daniel Sugrue, Sara Lopes, Thomas Ward, Sarah-Jane Anderson, Olivia Hayward, Yogesh Punekar
Publikováno v:
Journal of managed carespecialty pharmacy. 26(2)
As life expectancy of patients infected with human immunodeficiency virus (HIV) approaches that of the general population, the composition of HIV management costs is likely to change.To (a) review treatment and disease management costs in HIV, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af50492a9c3a8cf18479d51958f0d97
https://pubmed.ncbi.nlm.nih.gov/32011956
https://pubmed.ncbi.nlm.nih.gov/32011956
Autor:
Ben Parker, Sarah-Jane Anderson, Nicolas Van de Velde, Erin Arthurs, Debbie Becker, Vasiliki Chounta, Olivia Hayward, Amy Lee, I. Jacob
Publikováno v:
Open Forum Infectious Diseases
Background Current antiretroviral therapy (ART) has dramatically improved outcomes for people living with HIV (PLWHIV), however adherence to daily oral dosing remains a challenge for some. New, long-acting (LA) ARTs which are directly administered by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e31a97ee2fcfb3d583912c20cb098b
http://europepmc.org/articles/PMC7777051
http://europepmc.org/articles/PMC7777051
Autor:
Ahmed Yasine Ali, Ifor Delme Bowen, Richard W. E. Clarkson, Olivia Hayward, Troy Jackson, Daniel J. Turnham, Syn Kok Yeo
Publikováno v:
Phytotherapy Research. 30:418-425
The essential oils from Commiphora species have for centuries been recognized to possess medicinal properties. Here, we performed gas chromatography-mass spectrometry on the essential oil from opoponax (Commiphora guidotti) and identified bisabolene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::887fdb4459ee5c2bc59ea3da10420f8a
https://doi.org/10.1002/ptr.5543
https://doi.org/10.1002/ptr.5543
Autor:
Fraser L. Collins, Edward Chung Yern Wang, Zarabeth Newton, William Victor Perks, Anwen Sian Williams, Stephen Clark, Jason Peter Twohig, Olivia Hayward, Ravinder K. Singh
Publikováno v:
Arthritis & Rheumatology. 66:2762-2772
Objective: To investigate the role of death receptor 3 (DR-3) and its ligand tumor necrosis factor–like molecule 1A (TL1A) in the early stages of inflammatory arthritis. Methods: Antigen-induced arthritis (AIA) was generated in C57BL/6 mice deficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ccc95a0d4855ebf291a97ca240fd7f9
https://doi.org/10.1002/art.38770
https://doi.org/10.1002/art.38770
Autor:
Sarah-Jane Anderson, Olivia Hayward, Ben Parker, I. Jacob, Debbie Becker, Thomas Ward, Philip Christopher McEwan, N Van de Velde, Vasiliki Chounta, Erin Arthurs
Publikováno v:
Value in Health. 22:S642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::649e91fd8d1c2e4845b00f42fcca664d
https://doi.org/10.1016/j.jval.2019.09.1260
https://doi.org/10.1016/j.jval.2019.09.1260
Publikováno v:
Molecular Cancer
Background The clinical application of TRAIL receptor agonists as a novel cancer therapy has been tempered by heterogeneity in tumour responses. This is illustrated in breast cancer, where TRAIL is cytotoxic in cell lines of mesenchymal origin but re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3396a93cb5540476dad5d80aa3e2b4
https://orca.cardiff.ac.uk/id/eprint/84192/1/art%3A10.1186%2Fs12943-015-0478-y.pdf
https://orca.cardiff.ac.uk/id/eprint/84192/1/art%3A10.1186%2Fs12943-015-0478-y.pdf
